A new imaging method for detecting tumors early
Official title: A new highly sensitive targeted imaging method for early tumor detection
Funded at Icahn School of Medicine at Mount Sinai · NIH-10837132 · Data updated 2026-11-12
This study is working on a new way to spot tumors early by using special imaging agents that target a specific marker in tumor blood vessels, which could help improve cancer detection and treatment for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | May 8, 2023 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $191,337 |
| NIH project number | 5R21CA274007-02 |
| Project ID | NIH-10837132 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at high risk of developing cancer, particularly those with a family history or other risk factors.
✕Less likely to help
Patients with advanced-stage cancers that are already symptomatic may not benefit from this early detection method.
What this research studies
This research focuses on developing a highly sensitive imaging technique that targets a specific marker found in tumor blood vessels, known as the Follicle Stimulating Hormone Receptor (FSHR). The approach involves creating imaging agents that bind to FSHR and testing their effectiveness in cell cultures and in mice with implanted human tumors. By identifying tumors at their earliest stages, this method aims to improve early detection, which is crucial for successful treatment outcomes. The ultimate goal is to contribute to national efforts in reducing cancer mortality through better screening methods.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of various cancers, significantly improving treatment outcomes and survival rates.
How similar studies have gone: Previous research has shown promise in using targeted imaging techniques for cancer detection, suggesting that this approach could be a valuable advancement in the field.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Radu, Aurelian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Radu, Aurelian
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genetically Validated PCOS Subtypes for Better Diagnosis and Risk Stratification
Aimed at women with polycystic ovary syndrome (PCOS), this project uses genetic data and patient characteristics to define distinct PCOS subtypes and improve how we diagnose and estimate risk.
-
Closed-loop control of interneuron timing to influence seizures and memory in epilepsy
A study tests a brain-quieting system that uses light to precisely time certain brain cells in epilepsy-prone mice to see if this can lessen seizures and improve memory.
-
Understanding why some brain regions and cells accumulate tau in Alzheimer’s and related diseases
Researchers are studying why certain brain areas and neuron types accumulate tau protein in Alzheimer’s and related conditions, and how this leads to brain changes and symptoms.
-
Improving blood flow after stroke by breaking down NETs
Aims to see if breaking down neutrophil extracellular traps (NETs) after an ischemic stroke can improve blood flow and reduce brain injury in patients.
-
Aging and brain injury connection: learning how late-life TBI relates to Alzheimer’s and related dementias
This grant looks at whether traumatic brain injuries in people 65 and older are linked to Alzheimer’s disease and related dementias, using a large, harmonized set of long-term aging studies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.